Hi-Clearance Inc. (TPEX:1788)
Taiwan · Delayed Price · Currency is TWD 136.50
-0.50 (-0.36%)
At close: Dec 5, 2025
Hi-Clearance Revenue
Hi-Clearance had revenue of 1.07B TWD in the quarter ending September 30, 2025, with 5.62% growth. This brings the company's revenue in the last twelve months to 4.19B, up 3.34% year-over-year. In the year 2024, Hi-Clearance had annual revenue of 4.07B with 4.54% growth.
Revenue (ttm)
4.19B
Revenue Growth
+3.34%
P/S Ratio
1.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.07B | 177.03M | 4.54% |
| Dec 31, 2023 | 3.90B | -793.91M | -16.93% |
| Dec 31, 2022 | 4.69B | 1.01B | 27.30% |
| Dec 31, 2021 | 3.68B | 252.04M | 7.34% |
| Dec 31, 2020 | 3.43B | 191.25M | 5.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| EirGenix | 936.18M |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |